GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Suven Life Sciences SUVEN.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

279.95

+5.70%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹71.1m

FY2017FY2026

Net income

−₹2.76bn

FY2017FY2026

Free cash flow

−₹3.03bn

FY2017FY2026

Shareholders' equity

₹5.91bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹71.1m₹66.6m₹116.9m₹135.4m₹118.4m₹134.8m₹144.1m₹6.45bn₹6.13bn₹5.44bn
Research and development₹2.48bn₹1.44bn₹1.14bn₹1.15bn₹1.06bn₹710.3m₹1.03bn₹1.09bn₹796.9m₹991.5m
Operating income−₹2.90bn−₹1.72bn−₹1.23bn−₹1.32bn−₹1.26bn−₹838.7m−₹1.19bn₹1.70bn₹2.30bn₹1.29bn
Net income−₹2.76bn−₹1.61bn−₹1.05bn−₹1.18bn−₹1.22bn−₹721.5m−₹942.2m₹869.4m₹1.24bn₹871.9m
Diluted earnings per share-9.78-7.18-4.81-7.47-7.71-4.56-5.955.507.825.51

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹6.24bn₹1.35bn₹2.85bn₹3.89bn₹1.08bn₹1.28bn₹1.82bn₹10.39bn₹9.14bn₹8.16bn
Cash and short-term investments₹5.18bn₹600.0m₹2.40bn₹2.31bn₹504.4m₹463.5m₹147.3m₹2.43bn₹2.99bn₹3.10bn
Total liabilities₹328.1m₹252.0m₹148.6m₹135.9m₹118.9m₹204.1m₹385.8m₹2.08bn₹1.46bn₹1.49bn
Debt₹166.9m—₹7.1m₹16.1m₹32.1m₹47.6m₹60.1m₹380.1m₹283.6m₹707.8m
Shareholders' equity₹5.91bn₹1.10bn₹2.70bn₹3.75bn₹961.5m₹1.08bn₹1.43bn₹8.31bn₹7.67bn₹6.67bn
Shares outstanding283m224m219m158m158m158m158m158m158m158m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−₹2.98bn−₹1.48bn−₹1.15bn−₹1.03bn−₹1.28bn−₹960.2m−₹1.94bn₹355.5m₹699.4m₹1.09bn
Capital spending−₹50.8m−₹372.8m−₹1.16bn−₹28.9m−₹197.7m−₹63.0m−₹23.9m−₹975.6m−₹417.9m−₹305.4m
Free cash flow−₹3.03bn−₹1.86bn−₹2.31bn−₹1.06bn−₹1.47bn−₹1.02bn−₹1.96bn−₹620.1m₹281.4m₹783.0m
Dividends paid———————−₹230.2m−₹190.9m−₹153.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹35.7m₹15.2m₹28.1m₹9.2m₹18.7m₹14.7m₹16.1m₹25.7m
Operating income−₹1.35bn−₹522.2m−₹1.05bn−₹810.9m−₹521.2m−₹451.7m−₹407.4m−₹536.6m
Net income−₹1.28bn−₹456.0m−₹1.02bn−₹773.1m−₹515.2m−₹439.4m−₹391.2m−₹496.4m
Diluted earnings per share-4.52-1.61-4.55-3.45-2.30-1.96-1.79-2.27
Cash from operations———−₹1.03bn—−₹1.54bn—−₹802.0m
Capital spending———−₹21.0m—−₹372.0m——
Free cash flow———−₹1.05bn—−₹1.91bn——
Total assets—₹6.24bn—₹3.37bn—₹1.35bn—₹2.12bn
Cash and short-term investments—₹5.18bn₹2.57bn₹2.59bn₹600.0m₹600.0m₹1.66bn₹1.66bn
Debt—₹166.9m—————₹2.4m
Shareholders' equity—₹5.91bn₹2.81bn₹2.81bn₹1.10bn₹1.10bn₹1.93bn₹1.93bn

Financial ratios

Data as of 21 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin-4077.7%-2578.1%-1048.3%-974.3%-1065.6%-622.3%
Net margin-3884.1%-2415.1%-898.6%-873.5%-1030.0%-535.3%
Return on equity-46.7%-146.1%-38.9%-31.5%-126.9%-66.8%
Return on assets-44.3%-118.9%-36.9%-30.4%-112.9%-56.2%
Free cash flow yield-3.1%-1.5%0.0%-1.9%-2.0%-1.7%
Revenue growth6.9%-43.1%-13.6%14.3%-12.1%-6.5%
Earnings growth71.9%53.0%-11.2%-3.1%69.1%-23.4%
Current ratio17.69x3.21x18.99x22.61x8.01x6.45x
Debt to equity0.03x0.00x0.00x0.00x0.02x0.02x
Equity ratio94.7%81.4%94.8%96.5%89.0%84.1%
Interest coverage-1838.51x-3682.30x-410.66x-320.34x-188.92x-89.15x
R&D as a share of sales3488.4%2163.0%978.6%852.0%898.0%527.0%
Buybacks as a share of market value-26.1%-2.5%-38.1%0.0%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-19.3%-12.0%-34.6%
Operating income30.0%28.2%—
Net income32.7%30.8%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-3352.9%-1836.3%-1440.0%-18.2%
Net margin-3174.1%-1693.3%-1328.5%-24.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-28.8-23.2-26.6-10.8-8.9-18.0-14.02.61.41.7
Price to sales——239.194.491.496.491.60.30.30.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 14 Feb 2019.

FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012
Paid in the year1.3821.3820.9211.4741.8430.2760.2760.23
  • 2-for-1 split · 23 Mar 2007
  • 5-for-1 split · 16 Jan 2004

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.